Is cytokine-induced sensorineural hearing loss reversible?

Arthritis and Rheumatism

Volumn 58, Issue 12, 2008, Pages 3970-

  Imashuku, Shinsaku ^a  

^a Takasago seibu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

FEBRILE BONE MARROW APLASIA; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; LETTER; MUCKLE WELLS SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERCEPTION DEAFNESS; PRIORITY JOURNAL;

ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; HEARING LOSS, SENSORINEURAL; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RECOVERY OF FUNCTION;

EID: 57349171331     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24022     Document Type: Letter

References (6)

1. Yamazaki T, Masumoto J, Agematsu K, Sawai N, Kobayashi S, Shigemura T, et al. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum 2008;58:864-8.
2. Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 2006;54:1697-700.
3. Rynne M, Maclean C, Bybee A, McDermott MF, Emery P. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann Rheum Dis 2006;65:533-4.
4. Dalgic B, Egritas O, Sari S, Cuisset L. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra. Pediatr Nephrol 2007;22:1391-4.
5. Sundel RP, Newburger JW, McGill T, Cleveland SS, Miller WW, Berry B, et al. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr 1990;117:371-7.
6. Imashuku S, Kohdera U, Teramura T, Ueda I, Morimoto A, Naya M, et al. Sensorineural hearing loss in a case of familial hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;49:856-8.